Cogeno Life Science Private Limited - Company Profile

It is a jewelry & fashion accessories private limited company based in Delhi, Delhi, India, established in 2020.
2020 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Cogeno Life Science Private Limited

Cogeno Life Science Private Limited, a struck off private limited company, was established on 16 December 2020 in Delhi, Delhi, India. Engaging in watches and clocks within the jewelry & fashion accessories sector, it holds CIN: U33302DL2020PTC374572. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Arunesh Arya (Director), Neeru Mehra (Director), Sahil Taneja (Director). It is based at Unit No. 705, Aggarwal Corporate Tower, Plot No 23, Dis. Centre Rajendra Place, Delhi, Delhi, 110008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33302DL2020PTC374572

  • Registration Number

    374572

  • Incorporation Date

    16 December 2020

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 5 Months
Company report

Cogeno Life Science Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Cogeno Life Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cogeno Life Science Private Limited?
Current Directors
Name Designation Appointment Date Status
Arunesh Arya Director 16 Dec 2020 Current
Neeru Mehra Director 16 Dec 2020 Current
Sahil Taneja Director 16 Dec 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cogeno Life Science.

Enhance accessibility to Cogeno Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cogeno Life Science revenue growth over time
Cogeno Life Science profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cogeno Life Science?

Unlock access to Cogeno Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cogeno Life Science?

Cogeno Life Science has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cogeno Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cogeno Life Science's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cogeno Life Science
Recent Activity within the Organization
  • Director Appointment

    The activity Arunesh Arya was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Director Appointment

    Neeru Mehra was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Sahil Taneja was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Company Incorporation

    Cogeno Life Science Private Limited was registered on 16 Dec 2020 with Roc Delhi & aged 5 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cogeno Life Science Private Limited?

The CIN of Cogeno Life Science Private Limited is U33302DL2020PTC374572.

Where is Cogeno Life Science Private Limited headquartered?

Cogeno Life Science Private Limited is headquartered at Unit No. 705, Aggarwal Corporate Tower, Plot No 23, Dis. Centre Rajendra Place, Delhi, Delhi, 110008.

When was Cogeno Life Science Private Limited incorporated?

Cogeno Life Science Private Limited was incorporated on 16 December 2020.

Who are the current directors of Cogeno Life Science Private Limited?

The current directors of Cogeno Life Science Private Limited are

What is the primary industry of Cogeno Life Science Private Limited?

The primary industry of Cogeno Life Science Private Limited is Jewelry & Fashion Accessories.

Is Cogeno Life Science Private Limited a listed company?

Cogeno Life Science Private Limited is unlisted.

What is the capital structure of Cogeno Life Science Private Limited?

The authorized capital of Cogeno Life Science Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available